Gain the commercialization knowledge CEOS need to strategically position their organizations for financing success and meeting critical milestones.
Learn about the science driving today’s hottest biopharma innovations including CRISPR, CAR-T, gene therapy, and much more...
Explore a broad range of issues faced by entrepreneurs from the managerial, scientific, and academic communities...
Learn the most effective strategies for approaching institutional investors for a Series B or later...
Learn from senior executives to expertly navigate transactional and intellectual property law; business development; finance...
Learn from experienced dealmakers a review of example models, a dissection of actual deals, have live participant interaction and Q&A opportunities.
Enhance your skills in negotiations, influencing, decision-making, and game theory. Game theory will be applied to real-life pharma/biotech negotiation cases.
Gain a systematic approach to producing a valuation that can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world...
OSHA Bloodborne Pathogens Regulations details current OSHA Bloodborne Pathogen Regulations, how to determine if your organization is subject to its laws, and how to properly integrate them into existing medical surveillance, health, and safety programs.
What are considered good publication practices for communicating company-sponsored medical research and how do these practices impact publication development and planning? Learn more in this pub planning module.
A good regulatory strategy is essential to a good business strategy.
What are considered good publication practices for communicating company-sponsored medical research and how do these practices impact publication development and planning? Learn more in this pub planning module.
Learn the science of immunotherapy, cell and gene therapy, RNA-based drugs, and more.
Learn the foundational science and the regulatory approval process for gene therapies.
Learn how to develop and gain regulatory approval for medical devices.
What’s the difference between primary, secondary, and tertiary references and which are acceptable for use and why? Learn more in this referencing module.
Under what conditions can companies find a safe harbor for communicating investigational data? How and why is scientific exchange codified in the Code of Federal Regulations (CFR). Learn the FDA regs and more.
Statistical Features of Diagnostics surveys the measurements used to assess a diagnostic’s accuracy.
Gain a comprehensive understanding of DNA, proteins, and cells, explaining how they are manipulated to create innovative therapies and diagnostic tools.
The Regulatory Process provides a summary of the regulatory bodies involved in approving both small molecule drugs and biologics.
Who are the FDA, OIG, PhRMA, AMA, and ACCME? Why do these organizations expect you to comply with their rules, codes, and...
